John F. Ginascol, EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES (ABT), sold 6,241 shares at $118.16 ($762K) on 2021-03-01, disclosed to the SEC on 2022-03-02.
Scheduled sale ($762k) by EXECUTIVE VICE PRESIDENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.16 | 365 | $43K | 5.7% |
| 2 | $122.41 | 5,876 | $719K | 94.3% |
| Total | $122.16 avg | 6,241 | $762K | 100% |
| Filing → |
| ABT | SELL | 2021-03-02 | $42K | — | Filing → |
| ABT | SELL | 2020-04-23 | $12.1M | — | Filing → |
| ABT | SELL | 2020-03-03 | $591K | — | Filing → |